HomeCompareFLDPF vs JNJ

FLDPF vs JNJ: Dividend Comparison 2026

FLDPF yields 357142.86% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FLDPF wins by $1.6141616570133131e+32M in total portfolio value
10 years
FLDPF
FLDPF
● Live price
357142.86%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6141616570133131e+32M
Annual income
$161,327,306,237,090,300,000,000,000,000,000,000,000.00
Full FLDPF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — FLDPF vs JNJ

📍 FLDPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLDPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLDPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLDPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLDPF
Annual income on $10K today (after 15% tax)
$30,357,142.86/yr
After 10yr DRIP, annual income (after tax)
$137,128,210,301,526,750,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, FLDPF beats the other by $137,128,210,301,526,750,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLDPF + JNJ for your $10,000?

FLDPF: 50%JNJ: 50%
100% JNJ50/50100% FLDPF
Portfolio after 10yr
$8.0708082850665655e+31M
Annual income
$80,663,653,118,545,150,000,000,000,000,000,000,000.00/yr
Blended yield
99.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FLDPF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLDPF buys
0
JNJ buys
0
No recent congressional trades found for FLDPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLDPFJNJ
Forward yield357142.86%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1.6141616570133131e+32M$30.3K
Annual income after 10y$161,327,306,237,090,300,000,000,000,000,000,000,000.00$4,689.40
Total dividends collected$1.6141034966883305e+32M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLDPF vs JNJ ($10,000, DRIP)

YearFLDPF PortfolioFLDPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$35,724,986$35,714,285.71$10,592$272.30+$35.71MFLDPF
2$119,280,501,150$119,242,275,414.84$11,289$357.73+$119280.49MFLDPF
3$372,214,091,678,577$372,086,461,542,346.40$12,123$472.89+$372214091.67MFLDPF
4$1,085,532,457,599,806,200$1,085,134,188,521,710,200.00$13,141$629.86+$1085532457599.79MFLDPF
5$2,958,831,214,104,900,300,000$2,957,669,694,375,268,500,000.00$14,408$846.81+$2958831214104900.50MFLDPF
6$7,537,472,246,119,365,000,000,000$7,534,306,296,720,273,000,000,000.00$16,021$1,151.60+$7537472246119365632.00MFLDPF
7$17,945,693,732,569,136,000,000,000,000$17,937,628,637,265,787,000,000,000,000.00$18,122$1,588.22+$1.7945693732569136e+22MFLDPF
8$39,932,330,963,355,816,000,000,000,000,000$39,913,129,071,061,966,000,000,000,000,000.00$20,930$2,228.20+$3.993233096335581e+25MFLDPF
9$83,046,228,262,621,750,000,000,000,000,000,000$83,003,500,668,490,960,000,000,000,000,000,000.00$24,792$3,191.91+$8.304622826262175e+28MFLDPF
10$161,416,165,701,331,310,000,000,000,000,000,000,000$161,327,306,237,090,300,000,000,000,000,000,000,000.00$30,274$4,689.40+$1.6141616570133131e+32MFLDPF

FLDPF vs JNJ: Complete Analysis 2026

FLDPFStock

Frontline Gold Corporation, a junior mineral exploration company, acquires, explores for, and evaluates natural resource properties in Canada and Turkey. Its primary assets include Cameron Lake/Flint Lake property that comprises 21 mining claims located in the Rainy River area, Ontario; the Copperlode property consisting of 25 claim cells and 7 boundary cells covering an area of approximately 540 hectares; the Crooked Pine Lake project comprising of 8 multi-cell claims totaling 5,703 hectares situated in Ontario; and the Menderes gold project, which include 4 permits consisting of 6,194 hectares located in Turkey. The company also holds interest in the Red Lake mining division that comprises seven claim groups totaling 262 individual claims covering 4,900 hectares located in Red Lake, Ontario; the Whitehorse Island property that consists of two claims covering a total area of 35.55 hectares; the Portage River project consisting of 28 claims covering an area of 1,567 hectares located to the north of La Sarre, Quebec; the Route 109 project that comprises of 100 mining claims covering an area of approximately 5,588 hectares located in Matagami, Quebec; the Granite Ridge property that includes 49 claims covering an area of 995 hectares located in Ontario; and the Paint Lake Road property, which consists of 6 claims covering 3,610 hectares located in Ontario. In addition, it holds interest in the Epworth project consisting of 5 claims covering an area of 1,300 hectares situated in Nunavut; and the NE Bachelor property that consists of 62 mining claims covering 3,454 hectares located in Waswanipi, Quebec. The company was formerly known as Chrysos Capital Corporation and changed its name to Frontline Gold Corporation in March 2010. Frontline Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.

Full FLDPF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FLDPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLDPF vs SCHDFLDPF vs JEPIFLDPF vs OFLDPF vs KOFLDPF vs MAINFLDPF vs ABBVFLDPF vs MRKFLDPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.